menu toggle

July 16, 2026

Now available LUMVOA

LUMVOA (veligrotug-vvze) injection, for intravenous use, is an insulin-like growth factor-1 receptor inhibitor indicated for the treatment of thyroid eye disease regardless of thyroid eye disease activity or duration.

Please see full prescribing information.